why choose us

First received: August 23, 2022

Clinical Trial: "Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Benign Pancreatic Neoplasm

Study Type: INTERVENTIONAL


Official Title: Nanopore Sequencing for Detecting Bacteria in Bile and Preventing Surgical Site Infections in Patients Undergoing Surgery for Benign or Malignant Pancreatic Tumors

Brief Summary: This early phase I trial evaluates nanopore sequencing for its ability to detect bacteria in bile and prevent surgical site infections in patients undergoing surgery for benign or malignant pancreatic tumors.Surgical site infections are a significant source of poor outcomes in patients undergoing surgery for pancreatic tumors.In most patients who develop this kind of infection, the bacteria identified as causing the infection is also frequently found to be in the bile at time of surgery.Using nanopore sequencing…

Read more